Abstract
Young adults below 35 years of age who do not have an exceedingly rare genetic disorder such as familial hypercholesterolemia are at very low short-term (5- to 10-year) risk for coronary heart disease (CHD), and lipid-lowering treatment at this stage in life is unlikely to provide any short-term
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
